Ноотропы в комплексной терапии хронической ишемии мозга [PDF]
, 2014 Изложена клинико-фармакологическая характеристика ноотропов – одной из наиболее продуктивных групп нейропсихотропных лекарственных препаратов. Построена классификация ноотропных средств по основному механизму действия.
Беленичев, И.Ф. +6 more
core +2 more sources
Treatment for chronic daily headache by using auxiliary and alternative methods [PDF]
, 2015 Chronic daily headache (CDH) is one of the top 10 causes of adult disability and one of the 5 most common causes of female disability. To treat patients with CDH is one of the most difficult tasks in neurological practice.
V. A. Golovacheva +2 more
core +2 more sources
Аллергия на лекарства и медикаменты [PDF]
, 2003 АНТИГИСТАМИННЫЕ ПРЕПАРАТЫЛЕКАРСТВЕННАЯ АЛЛЕРГИЯУЧЕБНЫЕ ПОСОБИЯИзложена патогенез, клиника, диагностика, профилактика и неотложная терапия лекарственной аллергии.
Новиков, Д. К. +2 more
core
QUANTITATIVE PHARMACO-EEG IN ACUTE CEREBRAL ISCHEMIA AND ITS DYNAMICS IN NOOTROPICS’APPLICATION CONDITIONS [PDF]
, 2014 Electroencephalography (EEG) is a useful method for examination of patients with several types of neurological disorders, including cerebral ischemia, encephalopathy and etc.
D. P. Khloponin +2 more
core +2 more sources
Cerebrolysin: spectrum of activity and research data. Part 2
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018 The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease.
N. D. Bukreeva, E. A. Rakityanskaya
doaj
Pre-dementia neurocognitive disorder: diagnostic and therapeutic aspects
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018 There are the concept of mild cognitive decline (Mild cognitive impairment - MCI) and current approaches to the diagnosis pre-dementia (symptomatic) stage of Alzheimer’s disease in this discussing article.
S. I. Gavrilova
doaj
Cerebrolysin: spectrum of activity and research data
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018 The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease.
N. D. Bukreeva, E. A. Rakityanskaya
doaj
Роль и место системной энзимотерапии в реабилитации больных острой и хронической ишемией головного мозга [PDF]
, 2008 Main effects of system enzyme therapy (SET) are antiinflammatory, fibrinolythic and immunomodulating. Combination of these effects proved to be important in the treatment of 30 patients with stroke and 30 patients with ischemic cerebrovascular diseas ...
V. Sergienko S. +5 more
core +2 more sources
Quality of life in headache patients with analgesic overuse and therapy efficiency [PDF]
, 2010 Patients satisfying the IHS criteria for analgesic-overuse headache (AOH) were investigated in during the withdrawal therapy: 25 of them received amitriptyline 25 mg twice a day and 10,0 ml of Cerebrolysin daily (20 intravenous infusions).
Larikova, T. I. +3 more
core
Когнітивні порушення у пацієнтів із хворобою паркінсона та можливості їх корекції [PDF]
, 2011 Вивчено стан когнітивних функцій у пацієнтів із хворобою Паркінсона та їх динаміку в результаті комплексного лікування з використанням препарату “Церебролізин” .
Білоус, Ірина Іванівна +4 more
core